Levels to watch: FTSE 100, DAX and Dow

It is now the FTSE 100’s turn to languish, while the DAX and Dow register new all-time highs.

FTSE 100 treads water

While the FTSE 100 has recovered from the lows of last week, and while the trend is still intact, gains above 7750 have proven fleeting at best.

However, for now, we should work on the basis that the current trend will reassert itself, with a push towards 7800. A drop back below 7683 would suggest a move lower is in progress, down to 7600 and then 7550.

FTSE 100 price chart

DAX finally breaks higher

The DAX has clocked up a fresh all-time high, moving above the November high.

Support is possible at 13,533 and then 13,427. A definitive breakout will require a daily close above 13,533. 

DAX price chart

Dow relentless in its climb

The Dow Jones continues to soar, helped by good earnings and the end of the US government shutdown.

Momentum is relentless, and dips are short-lived. Possible areas of support can be found at 26,152 and then 25,440.

Dow Jones price chart

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.